EyePoint Pharmaceuticals(DE:PV3B)
€0.23-0.02 (-7.14%)
DE:PV3B
EyePoint Pharmaceuticals earnings date
€0.23
At close:-0.02 (-7.14%)
EyePoint Pharmaceuticals (PV3B) Q2 2025 Earnings Report
1 Followers
DE:PV3B Q2 2025 EPS Results
- Actual EPS
- -EUR 0.77
- Consensus EPS
- -EUR 0.75
- Beat/Miss
- Missed by -EUR 0.02
- One Year Ago EPS
- -EUR 0.53
DE:PV3B Q2 2025 Revenue Results
- Actual Revenue
- EUR 4.86M
- Expected Revenue
- EUR 6.06M
- Beat/Miss
- Missed by -EUR 1.20M
- YoY Revenue Growth
- -43.73%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/06/2025
- Time
- Before Open
- Conference Call
- Wednesday, August 6, 2025
DE:PV3B Upcoming Earnings
EyePoint Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:PV3B Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PV3B Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.63- | -0.74 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.85-0.98 | -0.77 | -25.88% (-0.20) | |
| Aug 05, 2026 | 2026 (Q2) | -0.90-0.99 | -0.77 | -28.24% (-0.22) | |
| May 06, 2026 | 2026 (Q1) | -0.73-0.90 | -0.59 | -52.31% (-0.31) | |
| Mar 04, 2026 | 2025 (Q4) | -0.68-0.74 | -0.58 | -26.56% (-0.15) | |
| Nov 05, 2025 | 2025 (Q3) | -0.70-0.77 | -0.49 | -57.41% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.75-0.77 | -0.53 | -46.55% (-0.25) | |
| May 07, 2025 | 2025 (Q1) | -0.61-0.59 | -0.5 | -18.18% (-0.09) | |
| Mar 05, 2025 | 2024 (Q4) | -0.44-0.58 | -0.3 | -93.94% (-0.28) | |
| Nov 07, 2024 | 2024 (Q3) | -0.50-0.49 | -0.3 | -63.64% (-0.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

